Section 4: Clinical Pharmacy Services

4CPS-241

IMPACT OF ANTIBIOTIC PRESCRIBING IN AN EMERGENCY DEPARTMENT ON HOSPITAL STAYS, READMISSION AND MORTALITY

4CPS-240

THERAPEUTIC MONITORING OF VANCOMYCIN IN A COHORT OF PAEDIATRIC PATIENTS

4CPS-239

THERAPEUTIC DRUG MONITORING OF GENTAMICIN IN NEONATES

4CPS-238

EVALUATION OF EFFECTIVENESS OF COMPOUNDED ORAL VANCOMYCIN CAPSULES FOR TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION

4CPS-237

FEASIBILITY OF CONTINUOUS ADMINISTRATION OF ANTIMICROBIALS IN HOSPITAL: NOTHING IS EVER AS IT SEEMS?

4CPS-236

USE OF ETELCALCETIDE IN PATIENTS UNDERGOING HAEMODIALYSIS

4CPS-235

SYSTEMIC CORTICOSTEROIDS IN THE TREATMENT OF SARS-CoV-2 INFECTION

4CPS-234

GLUCOCORTICOID INDUCED HYPERGLYCAEMIA IN NON-DIABETIC PATIENTS IN AN EMERGENCY DEPARTMENT

4CPS-233

HOME MANAGEMENT OF ACUTE MULTIPLE SCLEROSIS OUTBREAK: ADAPTATION TO CORONAVIRUS PANDEMIC

4CPS-232

USE OF DUPILUMAB IN THE TREATMENT OF ATOPIC DERMATITIS IN REAL CLINICAL PRACTICE

4CPS-231

REAL WORLD DATA OF MONOCLONAL ANTIBODIES FOR THE TREATMENT OF HYPERLIPIDAEMIA: ANALYSIS 3 YEARS AFTER INTRODUCTION IN CLINICAL PRACTICE

4CPS-230

ANTIARRHYTHMIC THERAPY EVALUATION IN A HOSPITAL SETTING

4CPS-229

ANALYSIS OF CLINICAL PHARMACIST INTERVENTIONS IN THE HEART FAILURE DAY HOSPITAL.

4CPS-228

VERNAKALANT VERSUS FLECAINIDE FOR CONVERSION OF RECENT ONSET ATRIAL FIBRILLATION IN PATIENTS ATTENDING THE EMERGENCY DEPARTMENT

4CPS-227

HUMAN SERUM ALBUMIN: ANALYSIS OF USE

Pages